Diplomat Pharmacy (DPLO) PT Raised to $40 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Diplomat Announces 1st Quarter Financial Results
May 11, 2015 4:07 PM EDTFLINT, Mich., May 11, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended March 31, 2015. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2014.
First Quarter 2015 Highlights include:
Revenue of $625 million, an increase of 34% Total prescriptions dispensed of 194,000, an increase of 6% Gross margin of 6.6% versus 6.3% Adjusted EBITDA of $11.2 million, an increase of 36% Adjusted EPS of $0.09, versus $0.05... More


